N/A
N=69
Efficacy of Pain Neuroscience Education in Genito-Pelvic Pain/Penetration Disorder. A Randomized Controlled Trial.
Pain · Dysfunction Sexual
Bottom Line
View on ClinicalTrials.gov: NCT05114473 ↗Enrolled (actual)
69
Serious AEs
—
Results posted
May 2024
Primary outcome: Primary: Visual Analogue Scale — 5.3; 5.8; 5.1; 3.8 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Workshops (Other); Online-accessed material (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Valencia
- Primary completion
- Feb 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Visual Analogue Scale |
5.3; 5.8; 5.1; 3.8; 4.9; 4.9 | — |
| SECONDARY Pain Catastrophizing Scale |
25.2; 28.0; 22.4; 18.9; 20.4; 25.3 | — |
| SECONDARY Survey of Pain Attitudes |
45.1; 49.6; 52.4; 45.2; 50.9; 52.4 | — |
| SECONDARY Female Sexual Function Index |
18.9; 19.1; 19.5; 21.0; 20.8; 18.4 | — |
Summary
Patients suffering pelvic persistent pain deal with significant pain that affects their quality of life. Often, conservative treatment interventions are scarce for these patients and are therefore not considered. Education has been developed as a relevant tool in the treatment of patients who suffer from chronic pain or any other pain processing alterations, and has the potential to become a powerfull treatment alternative.
Eligibility Criteria
Inclusion Criteria
- Patients over 18 years-old suffering from dyspareunia for more than 3 months
Exclusion Criteria
- Patients suffering from a previous medical condition that explains logically the presence of pain
Data sourced from ClinicalTrials.gov (NCT05114473). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.